- SPANNR
- Posts
- Issue #50
Issue #50
Issue #50
May 11, 2023 | Issue #50
Good afternoon. Welcome back to another issue of Spannr – a very special edition, as it's our 50th issue! We've officially completed one full year of diving into the exciting field of longevity. As we commemorate this milestone, we're switching things up a bit this week.In this week's newsletter:🙌 What a difference a year makes🌐 Good reads from around the web
Reflecting on a year of Spannr
Issue #50...
It's a number that signifies more than just a count of newsletters. It represents our shared journey in understanding and exploring the intricate world of life extension.
A little over a year ago, we embarked on this mission, dedicated to shedding light on what we believe to be the biggest business and health story of all time: The unprecedented revolution in society stemming from the extension of human healthspan and lifespan.
We've only just begun to unveil the immense possibilities this field holds, and we're excited about what the future promises.
In celebration of our first year in this fast-paced, ever-evolving market, we wanted to pause, look back, and showcase some of the most impactful articles we've published.
Here are the highlights that you, our readers, have found the most enlightening and engaging:
Analyzing One of Aging’s Biggest Dilemmas: The Lack of Government Funding
A closer look at just how much importance the US government puts on aging.
2022 Longevity Funding Report
Here's all the fundraising data we independently collected for longevity-related companies in 2022.
From Family Doctors to Personalized Health Coaches: The Rise of Personalized Medicine
Deciphering 40-plus biomarkers all at once is near impossible... until now.
FDA Restricts NMN Sales: The Implications, Winners & Losers, & Other Rapid Reactions
With the NMN ban supposedly intact, there are several takeaways we can make.
An Introduction to the Longevity Industry: What it is, Growth & Companies
A great resource for those completely unaware of today's emerging longevity sector.
Sneaky Spirits: An Unbiased Look at Alcohol’s Effect on Longevity
A deep dive into the landmark studies on alcohol’s effects on mortality.
Barking Up the Right Tree: How Dogs Just Might Be the Key to Human Longevity
Today, dogs are helping humans in ways unimaginable.
Longevity Clinics: What They Are, Services & More
These clinics represent a new and emerging direction in healthcare.
Your support and curiosity have been the driving force behind every issue of Spannr. Thank you for subscribing, for reading, and for joining us in this journey.
Here's to many more years of discovery together!
Best,
The Spannr Team
Baby born from three people's DNA in UK first (BBC)
Rapamycin: The unlucky history of the most powerful anti-aging drug (Big Think)
Does our gut microbiota really influence our health and life expectancy? (The Conversation)
Billionaire Peter Thiel says he’s signed up to be cryogenically preserved when he dies so he can be revived in the future—but he’s ‘not convinced it works’ (Fortune)
Metformin and Autophagy: The Cellular Recycling Process Behind Aging (WSJ)
Artificial intelligence identifies anti-aging drug candidates targeting 'zombie' cells (Phys)
A longer life often means a worse death (Big Think)
The World’s Oldest Ultramarathon Runner Is Racing against Death (The Walrus)
Performance:
Latest Price: $113.057d-Return: 5.25%Market Cap: $11.55b
ABOUT SPANNR
We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.
If you have any questions about Spannr or want to get to know us better,
– we'd love to hear from you. We appreciate your interest in what we are creating.